Literature DB >> 9640156

Population based pharmacokinetic analysis: why do we need it; what is it; and what has it told us about anaesthetics?

P M Wright1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9640156     DOI： 10.1093/bja/80.4.488

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  10 in total

Review 1.  Clinical pharmacokinetics of the newer neuromuscular blocking drugs.

Authors:  D P Atherton; J M Hunter
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations.

Authors:  Carmen Walter; Claudia Knothe; Jörn Lötsch
Journal:  Clin Pharmacokinet       Date:  2016-07       Impact factor: 6.447

Review 3.  Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.

Authors:  Kate O'Hara; Ian M R Wright; Jennifer J Schneider; Alison L Jones; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-10-26       Impact factor: 4.335

Review 4.  Population pharmacokinetics/pharmacodynamics of anesthetics.

Authors:  Erik Olofsen; Albert Dahan
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

Review 5.  Pharmacokinetics and pharmacodynamics of rapacuronium bromide.

Authors:  William J Wight; Peter M C Wright
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 6.  Population clinical pharmacology of children: general principles.

Authors:  Brian J Anderson; Karel Allegaert; Nicholas H G Holford
Journal:  Eur J Pediatr       Date:  2006-06-29       Impact factor: 3.183

7.  First administration to man of Org 25435, an intravenous anaesthetic: A Phase 1 Clinical Trial.

Authors:  Ann E Rigby-Jones; J Robert Sneyd; Peter Vijn; Patrick Boen; Maurice Cross
Journal:  BMC Anesthesiol       Date:  2010-06-29       Impact factor: 2.217

8.  External evaluation of a published population pharmacokinetic model of valproic acid in Thai manic patients.

Authors:  Janthima Methaneethorn; Manupat Lohitnavy
Journal:  Eur J Hosp Pharm       Date:  2018-09-26

9.  Analysis of a Compartmental Model of Endogenous Immunoglobulin G Metabolism with Application to Multiple Myeloma.

Authors:  Felicity Kendrick; Neil D Evans; Bertrand Arnulf; Hervé Avet-Loiseau; Olivier Decaux; Thomas Dejoie; Guillemette Fouquet; Stéphanie Guidez; Stéphanie Harel; Benjamin Hebraud; Vincent Javaugue; Valentine Richez; Susanna Schraen; Cyrille Touzeau; Philippe Moreau; Xavier Leleu; Stephen Harding; Michael J Chappell
Journal:  Front Physiol       Date:  2017-03-17       Impact factor: 4.566

10.  Azemiopsin, a Selective Peptide Antagonist of Muscle Nicotinic Acetylcholine Receptor: Preclinical Evaluation as a Local Muscle Relaxant.

Authors:  Irina V Shelukhina; Maxim N Zhmak; Alexander V Lobanov; Igor A Ivanov; Alexandra I Garifulina; Irina N Kravchenko; Ekaterina A Rasskazova; Margarita A Salmova; Elena A Tukhovskaya; Vladimir A Rykov; Gulsara A Slashcheva; Natalya S Egorova; Inessa S Muzyka; Victor I Tsetlin; Yuri N Utkin
Journal:  Toxins (Basel)       Date:  2018-01-07       Impact factor: 4.546
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.